Description
The FERARI study, conducted between May and December 2020 in the Democratic Republic of Congo, evaluated 337 pregnant women receiving antenatal care. Participants were administered Hemoforce Plus Zinc® syrup, which contains Ferric Sodium EDTA. Within three weeks, the study observed a significant improvement in hemoglobin levels, alongside minimal side effects and high tolerability. These findings suggest that Hemoforce Plus Zinc® may serve as an effective and well-tolerated alternative to traditional iron therapies for treating iron deficiency anemia during pregnancy.
To read the full paper, click here